You have 9 free searches left this month | for more free features.

LIC

Showing 1 - 25 of 161

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Diabetic Neuropathies Trial in Ciudad de Mexico (Cocoa, Placebo)

Recruiting
  • Diabetic Neuropathies
  • Cocoa
  • Placebo
  • Ciudad de Mexico, Cdmx, Mexico
    Hospital Regional Lic. Adolfo López Mateos
Mar 25, 2022

Covid19 Trial in Mexico City (MSC, Control)

Unknown status
  • Covid19
  • Mexico City, Ciudad De Mexico CDMX (Mexico City), Mexico
    Hospital Regional Lic Adolfo Lopez Mateos
Nov 9, 2020

Sars Cov 2 Trial in Mexico City (Sublingual Methylene blue, Control patients)

Unknown status
  • Sars Cov 2
  • Sublingual Methylene blue
  • Control patients
  • Mexico City, Ciudad De Mexico CDMX (Mexico City), Mexico
    Hospital Regional Lic Adolfo Lopez Mateos
Nov 9, 2020

Can Undetectable = Untransmissible Change Life Course of

Recruiting
  • HIV/AIDS
    • Harare, Zimbabwe
      Beatrice Road Infectious Hospital
    Oct 14, 2022

    Beta Thalassemia Major Anemia Trial (SP-420)

    Not yet recruiting
    • Beta Thalassemia Major Anemia
    • (no location specified)
    Jan 20, 2023

    Hepatic Affection in Hemodialysis Iron Overload in Assiut

    Completed
    • Hepatic Injury
      • Assuit, Egypt
        Marwa Abokresha
      Aug 25, 2021

      Procrastination Trial in Basel (Cognitive-behavioral treatment (CBT), Imaginary pill treatment (IP))

      Recruiting
      • Procrastination
      • Cognitive-behavioral treatment (CBT)
      • Imaginary pill treatment (IP)
      • Basel, Switzerland
        University of Basel, Division of Clinical Psychologie and Psycho
      Feb 15, 2023

      MRI QSM Imaging for Iron Overload

      Recruiting
      • Hemochromatosis
      • Iron Overload
      • Magnetic Resonance Imaging (MRI)-based Quantitative Susceptibility Mapping (QSM)
      • Stanford, California
      • +1 more
      Aug 2, 2022

      Quantitative Susceptibility Mapping to Guide Iron Chelating

      Recruiting
      • MRI Scans
      • Quantitative Susceptibility Mapping (QSM) Magnetic Resonance Imaging (MRI)
      • R2* Magnetic Resonance Imaging (MRI)
      • New York, New York
      • +1 more
      Jan 19, 2022

      Anxiety, Depression, Alcohol Use Trial in Vancouver (Minder)

      Recruiting
      • Anxiety
      • +3 more
      • Minder
      • Vancouver, British Columbia, Canada
        University of British Columbia
      Nov 3, 2022

      Hyponatremia, Dengue, Inflammation Trial in Haedo, Buenos Aires (hyponatremia)

      Recruiting
      • Hyponatremia
      • +2 more
      • hyponatremia
      • Haedo, Buenos Aires, Argentina
      • +1 more
      Oct 31, 2023

      Neuropsychological Outcome After Cardiac Arrest

      Completed
      • Heart Arrest, Out-Of-Hospital
      • +5 more
      • Neuropsychological assessment
      • Aarhus, Denmark
      • +7 more
      Jul 1, 2022

      Eclampsia Trial in Cape Town (Point-of-care ultrasound)

      Recruiting
      • Eclampsia
      • Point-of-care ultrasound
      • Cape Town, Western Cape, South Africa
        Groote Schuur Hospital
      Jan 3, 2023

      Anxiety Disorders, Depression, Stress Disorder Trial (Transdiagnostic single-session treatment)

      Not yet recruiting
      • Anxiety Disorders
      • +2 more
      • Transdiagnostic single-session treatment
      • (no location specified)
      Mar 13, 2023

      Primary Health Care, Mental Disorder, Behavioral Symptoms Trial in Linköping (Implementation of the service delivery model

      Recruiting
      • Primary Health Care
      • +2 more
      • Implementation of the service delivery model primary care behavioral health
      • Linköping, Östergötland, Sweden
        Primärvårdscentrum
      Nov 30, 2022

      Migraine Trial in Charlestown (Stress Reduction Training A, active tVNS, Stress Reduction Training B)

      Recruiting
      • Migraine
      • Stress Reduction Training A
      • +3 more
      • Charlestown, Massachusetts
        Anthinoula A. Martinos Center
      Apr 6, 2022

      Iron Overload Due to Repeated Red Blood Cell Transfusions Trial in Worldwide (SPD602)

      Terminated
      • Iron Overload Due to Repeated Red Blood Cell Transfusions
      • Los Angeles, California
      • +11 more
      Jun 11, 2021

      Beta Thalassemia Intermedia Trial in Worldwide (IONIS TMPRSS6-LRx)

      Active, not recruiting
      • Beta Thalassemia Intermedia
      • Camperdown, New South Wales, Australia
      • +18 more
      Sep 23, 2022

      To Assess the Clinical Usefulness and Acceptability Level of the UP Online Group Format in Argentina as Well as Participants'

      Not yet recruiting
      • To Assess the Clinical Usefulness and Acceptability Level of the UP Online Group Format in Argentina as Well as Participants' Satisfaction
      • Unified Protocol
      • Buenos Aires, Ciudad Autónoma De Buenos Aires, Argentina
        Faculty of Psychology, University of Buenos Aires
      Mar 2, 2022

      Iron Overload Due to Repeated Red Blood Cell Transfusions Trial in Worldwide (SSP-004184AQ)

      Terminated
      • Iron Overload Due to Repeated Red Blood Cell Transfusions
      • Oakland, California
      • +8 more
      Jun 11, 2021

      A Long-term Follow-up Study in Subjects Who Received CTX001

      Enrolling by invitation
      • Beta-Thalassemia
      • +6 more
      • CTX001
      • New York, New York
      • +12 more
      Nov 18, 2022

      Thalassemia Trial in Worldwide (Luspatercept, Placebo, Best Supportive Care (BSC))

      Active, not recruiting
      • Thalassemia
      • Los Angeles, California
      • +16 more
      Aug 16, 2022

      VATS for Resection of Mediastinal Parathyroids

      Completed
      • Mediastinal Parathyroid Adenoma
      • Hyperparathyroidism
      • VATS resection of MEPA
      • (no location specified)
      Jan 21, 2023

      Tumor Disease - Development and Validation ofPatient Reported

      Recruiting
      • Cancer
      • Patient reported outcome measure
      • Heidelberg, Germany
        National Center for Tumor Diseases, University Hospital Heidelbe
      Apr 6, 2022

      Transfusional Iron Overload, Beta-Thalassemia Trial in Worldwide (SPD602)

      Terminated
      • Transfusional Iron Overload
      • Beta-Thalassemia
      • Boston, Massachusetts
      • +8 more
      Jun 10, 2021